8:40am ET
Health and Healthcare
UBS Very Bullish on Biotech Stocks Ahead of Second-Quarter Earnings
In a new research report, UBS analysts are very positive on some top biotech stocks before second-quarter earnings numbers hit the tape.
Companies
/Healthcare
AMGEN Inc
$377.35
▼ $5.12 (−1.34%) today
Markets closed · 3:21am ET
AMGN Coverage
Page 32
2:05pm ET
Health and Healthcare
Will Celgene Trigger Other Biotech Stock Splits?
Celgene has decided to join the stock split game. Even though stock splits change nothing fundamentally, 24/7 Wall St. would like to see several competing biotechs join in on the fun.
6:50am ET
Health and Healthcare
Short Sellers Remain Vigilant Against Top Biotech Stocks
ThinkstockShort sellers have many reasons to bet against a stock, some of which are hedging or part of a larger theme. Other reasons may be a bet against a company or sector,…
8:55am ET
Health and Healthcare
Analyst Cancer and Biotech Stock Picks From ASCO
ThinkstockAs the summer starts, a large agenda is out there for investors when it comes to top biotech and specialty pharmaceutical companies making announcements and presenting clinical data. The biggest health care…
6:53am ET
Jobs
Google Top Company for Pay and Benefits
Google topped all companies in terms of best pay and benefits in a new survey by online jobs site Glassdoor. The list was thick with tech and biotech companies.
8:30am ET
Health and Healthcare
Top Biotech Stocks for Cancer Cures From Cowen
ThinkstockThe conference season is starting to get into full swing, and for the top biotech stocks, that means an appearance at the American Society of Clinical Oncology yearly conference. Many of the…
3:35pm ET
Health and Healthcare
Why Investors Are Not Chasing Gilead Endlessly Higher
ThinkstockBy any stretch of normal measurement in earnings season, Gilead Sciences Inc. (NASDAQ: GILD) should have been a rocketing stock on Wednesday. Gilead blew away earnings and revenue estimates. Its Sovaldi Hepatitis…
4:48pm ET
Health and Healthcare
An Earnings Tale of Two Biotechs: Gilead vs. Amgen
ThinkstockGilead Sciences Inc. (NASDAQ: GILD) and Amgen Inc. (NASDAQ: AMGN) have both reported earnings. This is a definite difference in how the reports look, and it could throw a wild card report…
12:00pm ET
Health and Healthcare
Biotech Earnings Previews: Amgen, Biogen Idec, Gilead, Celgene
ThinkstockBiotech stocks took it on the chin during the sell-off. In fact, biotech stocks may have even led the sell-off of momentum stocks in a reality check. The problem is that after…
8:00am ET
Health and Healthcare
Who Bucked the Short Interest Trend in Biotech Stocks?
Thinkstock24/7 Wall St. has tracked the short interest in leading biotech and emerging pharmaceutical stocks. Many biotech stocks pulled back in late March, and short sellers moved in on many of them.…
10:50am ET
Health and Healthcare
Amgen Faces Cool Reception Over GSK Pact Termination
Amgen submitted an SEC Filing showing that, as of April 1, one of its subsidiaries and a GlaxoSmithKline subsidiary have terminated part and amended part of a collaboration agreement from 2009.
3:37pm ET
Health and Healthcare
Biotech Giants Now Priced Like Old World Drug Stocks
Most investors buying Big Pharma stocks these days are buying them for dividends and somewhat of a defensive position against stock market volatility. Investors who are buying biotechs generally are looking for…
8:20am ET
Health and Healthcare
Large Cap Biotechs Trading With Only Big Pharma P/E Ratios
In a new report from RBC, its analysts say that biotech stocks trading at some of the lowest forward multiples in years are very attractive for many investors. Here are the top…
8:55am ET
Health and Healthcare
Morgan Stanley Starts Mixed Coverage on Top Biotech Stocks
courtesy of Morgan StanleyLike many of its Wall Street peers, the brutal sell-off in the biotechnology space has Morgan Stanley taking a closer look at the top names. The firm initiated coverage…
8:40am ET
Investing
Top Analyst Upgrades and Downgrades: Apple, BlackBerry, Chesapeake, Citigroup, King Digital and More
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Thursday, March 27, 2014. They include Apple, BlackBerry, Chesapeake Energy, Citigroup and King Digital.